Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller gene

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 11, 2015, Pages 6952-6959

  Wang, Zenglei ^a   Wang, Yingna ^b   Cabrera, Mynthia ^a   Zhang, Yanmei ^b   Gupta, Bhavna ^a   Wu, Yanrui ^b   Kemirembe, Karen ^a   Hu, Yue ^b   Liang, Xiaoying ^a   Brashear, Awtum ^a   Shrestha, Sony ^a   Li, Xiaolian ^a   Miao, Jun ^a   Sun, Xiaodong ^c   Yang, Zhaoqing ^b   Cui, Liwang ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c Yunnan Institute of Parasitic Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; DIHYDROARTEMISININ PLUS PIPERAQUINE; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; ASSAY; CHILD; CHINA; DRUG EFFICACY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; KELCH PROPELLER GENE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROBIAL GENE; MONOTHERAPY; MYANMAR; PLASMODIUM FALCIPARUM; POINT MUTATION; PRIORITY JOURNAL; SURVIVAL RATE; DRUG EFFECTS; GENETICS; MALARIA, FALCIPARUM; MULTIDRUG RESISTANCE; MUTATION; PATHOGENICITY;

ARTEMISININS; CHINA; DRUG RESISTANCE, MULTIPLE; GENOTYPE; MALARIA, FALCIPARUM; MUTATION; MYANMAR; PLASMODIUM FALCIPARUM; QUINOLINES;

EID: 84946212028     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01255-15     Document Type: Article

References (40)

1. Amaratunga C, Sreng S, Suon S., Phelps ES, Stepniewska K, Lim P, Zhou C., Mao S, Anderson JM, Lindegardh N, Jiang H., Song J, Su XZ, White N.J., Dondorp AM, Anderson TJ, Fay MP, Mu J, Duong S, Fairhurst RM. 2012. Artemisinin-resistant Plasmodium falciparum in Pursat Province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis 12:851-858. http://dx.doi.org/10.1016/S1473-3099(12)70181-0.
2. Noedl H, Se Y, Schaecher K., Smith BL, Socheat D, Fukuda MM. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359:2619-2620. http://dx.doi.org/10.1056/NEJMc0805011.
3. Dondorp AM, Nosten F, Yi P., Das D, Phyo AP, Tarning J, Lwin K.M., Ariey F., Hanpithakpong W, Lee SJ, Ringwald P, Silamut K., Imwong M, Chotivanich K, Lim P., Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455-467. http://dx.doi.org/10.1056/NEJMoa0808859.
4. Hien TT, Thuy-Nhien NT, Phu N.H., Boni MF, Thanh NV, Nha-Ca NT, Thai LE, Thai HCQ, Toi PV, Thuan P.D., Long LE, Dong LE, Merson TL, Dolecek C, Stepniewska K., Ringwald P, White NJ, Farrar J, Wolbers M. 2012. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J 11:355. http://dx.doi.org/10.1186/1475-2875-11-355.
5. Bustos MD, Wongsrichanalai C, Delacollette C., Burkholder B. 2013. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010. Southeast Asian J Trop Med Public Health 44(Suppl 1):S201-S230.
6. Ashley EA, Dhorda M, Fairhurst R.M., Amaratunga C., Lim P, Suon S, Sreng S., Anderson JM, Mao S, Sam B, Sopha C., Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S., Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ, Tracking Resistance to Artemisinin Collaboration (TRAC). 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371:411-423. http://dx.doi.org/10.1056/NEJMoa1314981.
7. Phyo AP, Nkhoma S, Stepniewska K., Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp A.M., Lwin KM, Singhasivanon P, Day NP, White N.J., Anderson TJ, Nosten F. 2012. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379:1960-1966. http://dx.doi.org/10.1016/S0140-6736(12)60484-X.
8. Kyaw MP, Nyunt MH, Chit K, Aye M.M., Aye KH, Lindegardh N, Tarning J, Imwong M., Jacob CG, Rasmussen C, Perin J, Ringwald P., Nyunt MM. 2013. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One 8:e57689. http://dx.doi.org/10.1371/journal.pone.0057689.
9. Flegg JA, Guerin PJ, Nosten F, Ashley E.A., Phyo AP, Dondorp AM, Fairhurst RM, Socheat D, Borrmann S., Bjorkman A, Martensson A, Mayxay M., Newton PN, Bethell D, Se Y, Noedl H., Diakite M, Djimde AA, Hien TT, White NJ, Stepniewska K. 2013. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives. Malar J 12:411. http://dx.doi.org/10.1186/1475-2875-12-411.
10. Stepniewska K, Ashley E, Lee S.J., Anstey N., Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton P.N., Olliaro P., Osorio L, Price RN, Rowland M, Smithuis F., Taylor WR, Nosten F, White NJ. 2010. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 201:570-579. http://dx.doi.org/10.1086/650301.
11. Witkowski B, Amaratunga C, Khim N., Sreng S, Chim P, Kim S., Lim P, Mao S, Sopha C., Sam B, Anderson JM, Duong S, Chuor C.M., Taylor WRJ, Suon S, Mercereau-Puijalon O, Fairhurst RM, Menard D. 2013. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drugresponse studies. Lancet Infect Dis 13:1043-1049. http://dx.doi.org/10.1016/S1473-3099(13)70252-4.
12. Ariey F, Witkowski B, Amaratunga C., Beghain J, Langlois AC, Khim N, Kim S., Duru V, Bouchier C, Ma L., Lim P, Leang R, Duong S., Sreng S, Suon S, Chuor CM, Bout DM, Menard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Menard D. 2014. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505:50-55. http://dx.doi.org/10.1038/nature12876.
13. Witkowski B, Khim N, Chim P., Kim S, Ke S, Kloeung N., Chy S, Duong S, Leang R., Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A., Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D. 2013. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother 57:914-923. http://dx.doi.org/10.1128/AAC.01868-12.
14. Straimer J, Gnadig NF, Witkowski B, Amaratunga C., Duru V, Ramadani AP, Dacheux M, Khim N., Zhang L, Lam S, Gregory P.D., Urnov FD, Mercereau-Puijalon O, Benoit-Vical F, Fairhurst R.M., Menard D., Fidock DA. 2015. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347:428-431. http://dx.doi.org/10.1126/science.1260867.
15. Ghorbal MGM, Macpherson CR, Martins R.M., Scherf A., Lopez-Rubio JJ. 2014. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol 32:819-821. http://dx.doi.org/10.1038/nbt.2925.
16. Mok S, Ashley EA, Ferreira P.E., Zhu L., Lin Z, Yeo T, Chotivanich K., Imwong M, Pukrittayakamee S, Dhorda M., Nguon C, Lim P, Amaratunga C., Suon S, Hien TT, Htut Y, Faiz MA, Onyamboko MA, Mayxay M, Newton PN, Tripura R, Woodrow CJ, Miotto O, Kwiatkowski DP, Nosten F, Day NP, Preiser PR, White NJ, Dondorp AM, Fairhurst RM, Bozdech Z. 2015. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science 347:431-435. http://dx.doi.org/10.1126/science.1260403.
17. Mbengue A, Bhattacharjee S, Pandharkar T., Liu H, Estiu G, Stahelin R.V., Rizk SS, Njimoh DL, Ryan Y, Chotivanich K., Nguon C, Ghorbal M, Lopez-Rubio JJ, Pfrender M., Emrich S, Mohandas N, Dondorp AM, Wiest O, Haldar K. 2015. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 520:683-687. http://dx.doi.org/10.1038/nature14412.
18. Nyunt MH, Hlaing T, Oo H.W., Tin-Oo LL, Phway HP, Wang B, Zaw N.N., Han SS, Tun T, San KK, Kyaw M.P., Han ET. 2015. Molecular assessment of artemisinin resistance markers, polymorphisms in the K13 propeller, and a multidrug-resistance gene in the eastern and western border areas of Myanmar. Clin Infect Dis 60:1208-1215. http://dx.doi.org/10.1093/cid/ciu1160.
19. Takala-Harrison S., Jacob CG, Arze C, Cummings M.P., Silva JC, Dondorp AM, Fukuda MM, Hien T.T., Mayxay M., Noedl H, Nosten F, Kyaw M.P., Nhien NT, Imwong M, Bethell D, Se Y., Lon C, Tyner SD, Saunders DL, Ariey F, Mercereau-Puijalon O, Menard D, Newton PN, Khanthavong M, Hongvanthong B, Starzengruber P, Fuehrer HP, Swoboda P, Khan WA, Phyo AP, Nyunt MM, Nyunt MH, Brown TS, Adams M, Pepin CS, Bailey J, Tan JC, Ferdig MT, Clark TG, Miotto O, MacInnis B, Kwiatkowski DP, White NJ, Ringwald P, Plowe CV. 2015. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis 211:670-679. http://dx.doi.org/10.1093/infdis/jiu491.
20. Thriemer K, Hong NV, Rosanas-Urgell A, Phuc B.Q., Ha DM, Pockele E, Guetens P, Van N.V., Duong TT, Amambua-Ngwa A, D'Alessandro U, Erhart A. 2014. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam. Antimicrob Agents Chemother 58:7049-7055. http://dx.doi.org/10.1128/AAC.02746-14.
21. Conrad MD, Bigira V, Kapisi J., Muhindo M, Kamya MR, Havlir D.V., Dorsey G., Rosenthal PJ. 2014. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One 9:e105690. http://dx.doi.org/10.1371/journal.pone.0105690.
22. Kamau E, Campino S, Amenga-Etego L, Drury E., Ishengoma D, Johnson K, Mumba D., Kekre M, Yavo W, Mead D., Bouyou-Akotet M, Apinjoh T, Golassa L., Randrianarivelojosia M, Andagalu B, Maiga-Ascofare O, Amambua-Ngwa A, Tindana P, Ghansah A, MacInnis B, Kwiatkowski D, Djimde AA. 2014. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis 211:1352-1355. http://dx.doi.org/10.1093/infdis/jiu608.
23. Taylor SM, Parobek CM, DeConti D.K., Kayentao K., Coulibaly SO, Greenwood BM, Tagbor H, Williams J., Bojang K, Njie F, Desai M., Kariuki S, Gutman J, Mathanga D.P., Martensson A., Ngasala B, Conrad MD, Rosenthal PJ, Tshefu AK, Moormann AM, Vulule JM, Doumbo OK, ter Kuile FO, Meshnick SR, Bailey JA, Juliano JJ. 2015. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis 211: 680-688. http://dx.doi.org/10.1093/infdis/jiu467.
24. Torrentino-Madamet M., Fall B, Benoit N., Camara C, Amalvict R, Fall M., Dionne P, Fall KB, Nakoulima A, Diatta B., Dieme Y, Menard D, Wade B., Pradines B. 2014. Limited polymorphisms in K13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013. Malar J 13:472. http://dx.doi.org/10.1186/1475-2875-13-472.
25. Tun KM, Imwong M, Lwin K.M., Win AA, Hlaing TM, Hlaing T, Lin K., Kyaw MP, Plewes K, Faiz MA, Dhorda M, Cheah P.Y., Pukrittayakamee S., Ashley EA, Anderson TJ, Nair S, McDew-White M, Flegg J.A., Grist EP, Guerin P, Maude RJ, Smithuis F, Dondorp AM, Day NP, Nosten F, White NJ, Woodrow CJ. 2015. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis 15:415-421. http://dx.doi.org/10.1016/S1473-3099(15)70032-0.
26. Huang F, Takala-Harrison S, Jacob C.G., Liu H., Sun X, Yang H, Nyunt M.M., Adams M., Zhou S, Xiao Z, Ringwald P., Bustos MD, Tnag L, Plowe CV. 24 April 2015. A single mutation in K13 predominates in Southern China and is associated with delayed clearance of Plasmodium falciparum following artemisinin treatment. J Infect Dis http://dx.doi.org/10.1093/infdis/jiv249.
27. Wang Z, Shrestha S, Li X., Miao J, Yuan L, Cabrera M., Grube C, Yang Z, Cui L. 2015. Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007-2012. Malar J 14:168. http://dx.doi.org/10.1186/s12936-015-0672-9.
28. Talundzic E, Okoth SA, Congpuong K, Plucinski M.M., Morton L., Goldman IF, Kachur PS, Wongsrichanalai C, Satimai W., Barnwell JW, Udhayakumar V. 2015. Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog 11:e1004789. http://dx.doi.org/10.1371/journal.ppat.1004789.
29. Cui L, Su XZ 2009. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther 7:999-1013. http://dx.doi.org/10.1586/eri.09.68.
30. Sun X, Zhang Z, Wang J., Deng Y, Yang Y, Lasi J., Sun X, Wang H. 2011. Therapeutic efficacy and safety of compound dihydroartemis-inin/piperaquine for uncomplicated Plasmodium falciparum infection in Laiza city of Myanmar bordering on China. Chin J Parasitol Parasit Dis 29:372-375.
31. Huang F, Tang L, Yang H., Zhou S, Sun X, Liu H. 2012. Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border. Malar J 11:278. http://dx.doi.org/10.1186/1475-2875-11-278.
32. Wang Y, Yang Z, Yuan L., Zhou G, Lee M-C, Fan Q, Xiao Y., Cao Y, Yan G, Cui L. 2015. Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria at the China-Myanmar border. Am J Trop Med Hyg 93:577-583. http://dx.doi.org/10.4269/ajtmh.
33. Meng H, Zhang R, Yang H., Fan Q, Su X, Miao J., Cui L, Yang Z. 2010. In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger. Antimicrob Agents Chemother 54: 4306-4313. http://dx.doi.org/10.1128/AAC.00321-10.
34. Smilkstein M, Sriwilaijaroen N, Kelly J.X., Wilairat P., Riscoe M. 2004. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48:1803-1806. http://dx.doi.org/10.1128/AAC.48.5.1803-1806.2004.
35. Lambros C, Vanderberg JP 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65:418-420. http://dx.doi.org/10.2307/3280287.
36. Yang Z, Li C, Miao M., Zhang Z, Sun X, Meng H., Li J, Fan Q, Cui L. 2011. Multidrug-resistant genotypes of Plasmodium falciparum, Myanmar. Emerg Infect Dis 17:498-501. http://dx.doi.org/10.3201/eid1703.100870.
37. Gupta B, Xu S, Wang Z., Sun L, Miao J, Cui L., Yang Z. 2014. Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar. J Antimicrob Chemother 69:2110-2117. http://dx.doi.org/10.1093/jac/dku125.
38. Bandelt HJ, Forster P, Rohl A. 1999. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16:37-48. http://dx.doi.org/10.1093/oxfordjournals.molbev.a026036.
39. Menard D, Andriantsoanirina V, Khim N., Ratsimbasoa A, Witkowski B, Benedet C., Canier L, Mercereau-Puijalon O, Durand R. 2013. Global analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine. Int J Parasitol Drugs Drug Resist 3:8-19. http://dx.doi.org/10.1016/j.ijpddr.2012.10.001.
40. Hott A, Casandra D, Sparks K.N., Morton LC, Castanares GG, Rutter A, Kyle DE 2015. Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes. Antimicrob Agents Chemother 59:3156-3167. http://dx.doi.org/10.1128/AAC.00197-15.